207 related articles for article (PubMed ID: 28751757)
1. Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
Tangen IL; Kopperud RK; Visser NC; Staff AC; Tingulstad S; Marcickiewicz J; Amant F; Bjørge L; Pijnenborg JM; Salvesen HB; Werner HM; Trovik J; Krakstad C
Br J Cancer; 2017 Sep; 117(6):840-847. PubMed ID: 28751757
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.
Pasanen A; Loukovaara M; Tuomi T; Bützow R
Int J Gynecol Cancer; 2017 Sep; 27(7):1318-1324. PubMed ID: 29059097
[TBL] [Abstract][Full Text] [Related]
3. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
4. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Trovik J; Wik E; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; Njolstad TS; ; Vandenput I; Amant F; Akslen LA; Salvesen HB
Clin Cancer Res; 2011 May; 17(10):3368-77. PubMed ID: 21242118
[TBL] [Abstract][Full Text] [Related]
5. L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
van der Putten LJ; Visser NC; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MP; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Amant F; Massuger LF; Pijnenborg JM
Br J Cancer; 2016 Sep; 115(6):716-24. PubMed ID: 27505134
[TBL] [Abstract][Full Text] [Related]
6. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
7. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
8. L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.
Smogeli E; Davidson B; Cvancarova M; Holth A; Katz B; Risberg B; Kristensen G; Lindemann K
BMC Cancer; 2016 Aug; 16():596. PubMed ID: 27488577
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Van Gool IC; Stelloo E; Nout RA; Nijman HW; Edmondson RJ; Church DN; MacKay HJ; Leary A; Powell ME; Mileshkin L; Creutzberg CL; Smit VT; Bosse T
Mod Pathol; 2016 Feb; 29(2):174-81. PubMed ID: 26743472
[TBL] [Abstract][Full Text] [Related]
10. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
Soovares P; Pasanen A; Bützow R; Lassus H
Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
[TBL] [Abstract][Full Text] [Related]
11. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
13. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
14. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
Corrado G; Laquintana V; Loria R; Carosi M; de Salvo L; Sperduti I; Zampa A; Cicchillitti L; Piaggio G; Cutillo G; Falcioni R; Vizza E
J Exp Clin Cancer Res; 2018 Jul; 37(1):139. PubMed ID: 29980240
[TBL] [Abstract][Full Text] [Related]
16. The significance of L1CAM expression in clear cell carcinoma of the endometrium.
Fadare O; Roma AA; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Hecht JL; Parkash V; Wang XJ
Histopathology; 2018 Feb; 72(3):532-538. PubMed ID: 28941294
[No Abstract] [Full Text] [Related]
17. L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy.
Zeiter D; Vlajnic T; Schötzau A; Heinzelmann-Schwarz V; Montavon C
J Cancer; 2021; 12(21):6401-6410. PubMed ID: 34659530
[No Abstract] [Full Text] [Related]
18. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
19. L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy.
Asano H; Hatanaka KC; Matsuoka R; Dong P; Mitamura T; Konno Y; Kato T; Kobayashi N; Ihira K; Nozaki A; Oku A; Matsuno Y; Hatanaka Y; Watari H
Ann Surg Oncol; 2020 Jul; 27(7):2159-2168. PubMed ID: 31792716
[TBL] [Abstract][Full Text] [Related]
20. Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study.
Fonnes T; Trovik J; Edqvist PH; Fasmer KE; Marcickiewicz J; Tingulstad S; Staff AC; Bjørge L; Amant F; Haldorsen IS; Werner H; Akslen LA; Tangen IL; Krakstad C
BJOG; 2018 Dec; 125(13):1695-1703. PubMed ID: 29989298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
